Discussion on new technology of plant extraction

On September 19, Xi'an Lanxiao science and technology new materials Co., Ltd held the second seminar on separation and purification technology (plant extract) in Xi'an Experts and enterprise representatives in the industry exchanged and discussed the development and new technology of plant extraction industry Zhang Chengcheng, director of China plant extract association and chairman and general manager of Jiaowang Natural Products Co., Ltd., believes that the incorrect understanding of industrial marijuana should be dispelled China urgently needs to establish industrial technology clusters, establish national industry associations as soon as possible, and promote the healthy development of the industry According to reports, hemp, also known as hemp and jute, has a long history of use The active ingredients of hemp are rich in leaves and female flowers, mainly including THC, CBD, CBN, HND and THC Marijuana is a drug that has been banned for 100 years, but marijuana is not a "devil" The marijuana diphenol (CBD) contained in marijuana is the "angel" of persistent diseases, which has anti-tumor, depression, schizophrenia, multiple sclerosis, immune regulation, anti-inflammatory and analgesic effects In June 2018, the drugs developed by GW company for the treatment of epilepsy were approved by the US FDA, and other drugs are under development At present, Uruguay, Canada and other countries have supported the legalization of cannabis nationwide, while Argentina, Australia and most other countries support the legalization of medical cannabis Zhang Chengcheng believes that as plant extracts, industrial hemp, like taxol and coenzyme Q10, is a high value-added product oriented by drug demand, with similar structure and separation technology However, the technology is difficult and immature At the same time, there are certain policies and regulations in China From the perspective of the development of paclitaxel and coenzyme Q10, due to the vicious competition after the breakthrough of technical barriers, a high value-added product has been turned into a common product, affecting the industrial development Similar phenomena should be avoided in industrial cannabis In the field of industrial hemp CBD separation materials, Xi'an Lanxiao technology has formed a certain scale of sales Zhang Wei, manager of the R & D Department of the company, said that the extraction and purification technology of the active components of industrial marijuana is mainly solvent extraction Marijuana drugs can be used to treat severe and slow pain, Alzheimer's disease, opioid and nicotine dependence caused by later mental disorders For example, THC and CBD are used in the treatment of brain glioma, which is in the second stage of clinical; thcv is used in the treatment of type 2 diabetes, CBD is used in the treatment of schizophrenia, etc At the seminar, Chen Yuru, Professor of Nanjing Normal University, Li Duowei, Professor of Life Science College of Northwest University, Wang Chengzhang, researcher of forest products Chemical Industry Research Institute of Chinese Academy of forestry, technical director of Lanxiao technology and representatives of enterprises in the industry, respectively, focused on the development and application of natural products phenolic acid and rare glycoside health ingredients, extraction and separation of plant thermosensitive substances such as tea polyphenols Technology, characteristic forest source extract and processing separation technology, resin use and daily maintenance, chromatography technology and its industrial application, etc were exchanged and shared After the seminar, the participants visited Lanxiao company.